MCK stock is up nearly 5% amid reports that McKesson (NYSE:MCK), along with AmerisourceBergen (NYSE:ABC) and Cardinal Health (NYSE:CAH), is considering an $18 billion USD settlement to end lawsuits relating to its role in contributing to the opioid crisis.
The potential settlement would see the three firms pay $18 billion USD over the course of 18 years, and it is also being reported that Johnson & Johnson (NYSE:JNJ) could join the final version of the deal. The sweeping litigations, which have been brought by prosecutors representing state and local governments, accuse members of every aspect of ...
Read The Full Article On StreetSignals.com
Get the latest stock market news on StreetSignals. Follow public companies and get free stock research reports and stock market analysis data and stock tips.
All content provided by StreetSignals is subject to our Terms Of Use and Disclaimer.